Dr. Scott Frederick Michael Blumhof, DO

Dr. Blumhof practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Blumhof's NPI, 1568724946, was assigned on June 12, 2012. Dr. Blumhof graduated from Rowan University School of Osteopathic Medicine in 2012. Dr. Blumhof holds Pennsylvania license OS017456.

Dr. Blumhof's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Blumhof's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Blumhof is also affiliated with Lehigh Valley Hospital-Pocono. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Blumhof to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blumhof practices, 8 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Blumhof's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Blumhof is licensed in Pennsylvania.

CMS data shows 631 Medicare services from Dr. Blumhof across 11 procedure codes in 2024, for 378 Medicare patients. Medicare paid $57,830 for them.

CMS counts 378 Medicare patients who saw Dr. Blumhof in 2024. The largest group is 65 to 74, with 142 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blumhof's median patient age at 70, with 53% women.

In 2024, Dr. Blumhof wrote 1,216 Medicare Part D claims for 197 patients. 40% of them were for generic drugs. CMS names the drug for 1,075 of them, across 25 drugs with 11 or more claims each, at $1,254,867 in total drug cost. In 2023, CMS named 1,139 claims across 24 drugs.

Dr. Blumhof accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blumhof as offering telehealth.

Dmand AI links 3 papers to Dr. Blumhof, published from 2016 to 2018. Dr. Blumhof's most frequent co-authors are David Sherwood Wheeler, MD, Allison H. Ferris, MD and Jonathan Isaac Gotfried, MD.

Dmand AI links Dr. Blumhof to 1 clinical trial.

CMS Open Payments shows 61 general payments to Dr. Blumhof from 14 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 68% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $3,622.

Dr. Blumhof graduated from Rowan University School of Osteopathic Medicine in 2012.